SCHEMBL4276593

SCHEMBL4276593

Cc1cc(I)c(Cl)cc1Sc1ccc(F)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 3/20 0.40
▸ KMT2A Q03164 3/20 0.40
▸ MAPT P10636 3/20 0.36
▸ HTR1A P08908 2/20 0.36
▸ HTR3A P46098 2/20 0.36
▸ ALDH1A1 P00352 3/20 0.35
▸ NPSR1 Q6W5P4 2/20 0.35
▸ RHEB Q15382 2/20 0.35
▸ PDE7A Q13946 2/20 0.34
▸ HPGD P15428 2/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ AGBL2 Q5U5Z8 1/20 0.33
▸ SMN1; SMN2 Q16637 3/20 0.32
▸ NPC1 O15118 2/20 0.32
▸ RAB9A P51151 2/20 0.32
▸ KCNQ3 O43525 1/20 0.32
▸ KCNQ2 O43526 1/20 0.32
▸ RXRA P19793 1/20 0.31
▸ RXRB P28702 1/20 0.31
▸ RXRG P48443 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4277738 0.81 MAPT (0.43) MEN1KMT2AMAPTHTR1AHTR3A
SCHEMBL4284955 0.75 PDE7A (0.50) MEN1KMT2AMAPTALDH1A1NPSR1
SCHEMBL4277853 0.74 PTGES (0.45) MEN1KMT2AMAPTALDH1A1NPSR1
SCHEMBL4277854 0.74 PTGES (0.45) MEN1KMT2AMAPTALDH1A1NPSR1
SCHEMBL4286150 0.71 ALDH1A1 (0.41) MEN1KMT2AMAPTALDH1A1NPSR1
SCHEMBL4286153 0.71 ALDH1A1 (0.41) MEN1KMT2AMAPTALDH1A1NPSR1
SCHEMBL14364042 0.68 HTR1A (0.36) MEN1KMT2AMAPTHTR1AHTR3A
SCHEMBL2154888 0.66 AR (0.46) HTR1AHTR3AALDH1A1LMNA
SCHEMBL21856930 0.65 CD44 (0.36) ALDH1A1
SCHEMBL24928201 0.64 CD44 (0.46) ALDH1A1KDM4ESMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090099186-A1 INHIBITORS OF VIRAL REPLICATION INTERMUNE, INC. 2009-04-16 — — US disclosed
US-20090099186-A1 INHIBITORS OF VIRAL REPLICATION INTERMUNE, INC. 2009-04-16 — — US disclosed
US-20090099186-A1 INHIBITORS OF VIRAL REPLICATION INTERMUNE, INC. 2009-04-16 — — US disclosed
WO-2007047146-A2 INHIBITORS OF VIRAL REPLICATION INTERMUNE, INC. (US) 2007-04-26 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090099186-A1 INHIBITORS OF VIRAL REPLICATION EIF2AK2, HAVCR2, RTF2 MEN1 4395/4885KMT2A 2463/4885MAPT 4203/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback